Anchiano Discontinues Phase 2 Codex Study of Inodiftagene in Non-Muscle-Invasive Bladder Cancer; Will Focuse on Advancing Pan-RAS Inhibitors – CBI
Homepage /  Press Release /  Anchiano Discontinues Phase 2 Codex Study of Inodiftagene in Non-Muscle-Invasive Bladder Cancer; Will Focuse on Advancing Pan-RAS Inhibitors

Press Release

Anchiano Discontinues Phase 2 Codex Study of Inodiftagene in Non-Muscle-Invasive Bladder Cancer; Will Focuse on Advancing Pan-RAS Inhibitors